Unlock instant, AI-driven research and patent intelligence for your innovation.

Compound containing sulfonamide structure, preparation method and application of compound, pharmaceutical composition and application of pharmaceutical composition

A technology containing sulfonamides and compounds, applied to compounds containing sulfonamide structures and their preparation, pharmaceutical compositions and application fields

Pending Publication Date: 2022-03-01
NANJING SHUOHUI PHARMATECHNOLOGY CO LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] However, the marketed representative P-CABs Vonorazan also showed certain safety risks in clinical application, such as liver toxicity, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compound containing sulfonamide structure, preparation method and application of compound, pharmaceutical composition and application of pharmaceutical composition
  • Compound containing sulfonamide structure, preparation method and application of compound, pharmaceutical composition and application of pharmaceutical composition
  • Compound containing sulfonamide structure, preparation method and application of compound, pharmaceutical composition and application of pharmaceutical composition

Examples

Experimental program
Comparison scheme
Effect test

preparation example 1

[0093] Preparation Example 1: This preparation example is used to illustrate the synthesis process of the hydrochloride salt of Compound 1

[0094]

[0095] Step 1: Preparation of 5-bromo-1H-pyrrole-3-carbaldehyde

[0096] Pyrrole-3-carboxaldehyde (52.6mmol) and tetrahydrofuran (THF, 100mL) were added to a double-necked round bottom flask and placed in a low-temperature magnetic stirrer to cool to -78°C, and dissolved in N,N-dimethylformamide Bromosuccinimide (NBS, 52.6 mmol) in (DMF, 30 mL) was added dropwise into the reaction system. After the dropwise addition was completed and the reaction was continued for 1 h, the temperature was raised to -10° C. and the reaction was continued for 1 h. TLC monitored the complete reaction of the starting material. Add ice water to the system, extract with ethyl acetate (200mL×2), wash with saturated brine (150mL×2), combine the organic phases, dry over anhydrous sodium sulfate, and concentrate under reduced pressure to obtain a brow...

preparation example 2

[0108] Preparation Example 2: This preparation example is used to illustrate the synthesis process of the hydrochloride salt of Compound 2

[0109] The preparation method of this preparation example is similar to preparation example 1, and difference is:

[0110] Replace the (2S)-1,4-dioxane-2-methanol in step 6) with an equimolar amount of cyclobutylmethanol to obtain the hydrochloride salt of compound 2, a white solid, the one-step yield in step 6). rate 24%.

[0111] 1 H NMR (600MHz, Methanol-d 4 )δ8.87–8.83(m,1H),8.61(s,1H),8.01(d,J=8.4Hz,1H),7.80(s,1H),7.68–7.63(m,1H),7.00(t ,J=8.4Hz,1H),6.76(d,J=8.4Hz,1H),6.69–6.62(m,1H),6.40(d,J=1.8Hz,1H),4.10(s,2H),4.00 (d,J=6.6Hz,2H),2.86–2.77(m,1H),2.72(s,3H),2.23–2.11(m,2H),2.08–1.89(m,4H).

preparation example 3

[0112] Preparation Example 3: This preparation example is used to illustrate the synthesis process of the hydrochloride salt of compound 3

[0113] The preparation method of this preparation example is similar to preparation example 1, and difference is:

[0114] The (2S)-1,4-dioxane-2-methanol in step 6) was replaced by an equimolar amount of cyclopentylmethanol to obtain the hydrochloride salt of compound 3, a white solid, the one-step yield in step 6). rate 31%.

[0115] 1 H NMR (600MHz, Methanol-d 4 )δ8.87(d, J=4.8Hz, 1H), 8.63(s, 1H), 8.05(d, J=8.4Hz, 1H), 7.81(d, J=2.4Hz, 1H), 7.72–7.66( m,1H),7.00(t,J=8.4Hz,1H),6.76(d,J=8.4Hz,1H),6.67(d,J=11.4Hz,1H),6.41(d,J=1.8Hz, 1H), 4.10(s, 2H), 3.92(d, J=6.6Hz, 2H), 2.72(s, 3H), 2.44–2.32(m, 1H), 1.92–1.83(m, 2H), 1.75–1.58 (m,4H),1.47–1.35(m,2H).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the field of medicine, and discloses a compound containing a sulfonamide structure, a preparation method and application of the compound, a pharmaceutical composition and application of the pharmaceutical composition, the compound has the structure shown in the formula (I), and the compound can be used as a therapeutic agent, especially as a gastric acid secretion inhibitor and a potassium ion competitive acid blocker (P-CABs).

Description

technical field [0001] The invention relates to the field of medicine, in particular to a compound containing a sulfonamide structure, a preparation method and application thereof, a pharmaceutical composition and application thereof. Background technique [0002] Proton pump inhibitors (proton pump inhibitors, PPIs) represented by omeprazole strongly and persistently inhibit gastric acid secretion by inhibiting H+ / K+-ATPase on gastric parietal cells. Currently, PPIs are widely used in the treatment of gastroesophageal reflux Disease, peptic ulcer, Helicobacter pylori infection, upper gastrointestinal bleeding, Zollinger-Ellison syndrome and other acid-related diseases. [0003] Since 1988, long-term clinical application has found that due to the shortcomings of instability, short half-life, CYP2C19 gene polymorphism, limited medication time, and slow onset of action, PPI needs to be clinically effective faster and has an acid-suppressive effect. Stronger, longer-lasting an...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D405/14C07D405/12C07D401/12A61K31/4439A61K31/4025A61P1/04A61P1/00A61P29/00
CPCA61K31/4439C07D405/14C07D405/12C07D401/12A61P1/04A61P1/00A61P29/00
Inventor 黄伟杨光富陈涛赵树立龚溢王明书
Owner NANJING SHUOHUI PHARMATECHNOLOGY CO LTD